Endocarditis (Enterococcus faecium/faecalis)
Overview
Plain-Language Overview
Endocarditis caused by Enterococcus faecium or faecalis is an infection of the inner lining of the heart, particularly affecting the heart valves. This condition involves the cardiovascular system and can lead to serious complications if untreated. The bacteria enter the bloodstream and attach to damaged areas of the heart, forming infected clumps called vegetations. These vegetations can interfere with normal heart function and may break off, causing blockages in other parts of the body. Symptoms often include fever, fatigue, and heart murmurs, reflecting the infection and inflammation. This infection can severely impact overall health by damaging heart valves and causing systemic illness.
Clinical Definition
Endocarditis (Enterococcus faecium/faecalis) is a form of infective endocarditis characterized by bacterial colonization and infection of the endocardial surface, primarily the heart valves. It is caused by Enterococcus species, which are gram-positive cocci that commonly colonize the gastrointestinal and genitourinary tracts. The pathogenesis involves bacterial adherence to previously damaged or prosthetic heart valves, leading to the formation of vegetations composed of bacteria, fibrin, and platelets. This condition is clinically significant due to its potential to cause valvular destruction, heart failure, systemic emboli, and persistent bacteremia. Enterococcal endocarditis is often associated with resistance to multiple antibiotics, complicating treatment. It typically presents with fever, new or changing heart murmurs, and signs of systemic infection.
Inciting Event
Transient bacteremia from genitourinary or gastrointestinal tract colonized by Enterococcus faecium/faecalis initiates infection.
Invasive procedures such as urinary catheterization or endoscopy can introduce enterococci into the bloodstream.
Dental procedures in patients with poor oral hygiene or pre-existing valve disease may trigger bacteremia.
Intravenous catheter placement or other vascular interventions can seed bacteria into circulation.
Latency Period
Subacute onset over days to weeks is typical, reflecting slow vegetation growth and progressive valvular damage.
Symptoms may develop within 1 to 4 weeks after the inciting bacteremia or procedure.
Delayed presentation can occur due to indolent infection and nonspecific early symptoms.
Diagnostic Delay
Nonspecific symptoms such as fever and malaise often mimic other infections leading to delayed suspicion.
Negative initial blood cultures may occur if antibiotics were given prior to sampling.
Misattribution to other causes like pneumonia or urinary tract infection delays targeted evaluation for endocarditis.
Lack of classic peripheral stigmata such as Osler nodes or Janeway lesions reduces clinical suspicion.
Clinical Presentation
Signs & Symptoms
Fever is the most common presenting symptom due to systemic infection
Chills and night sweats reflecting ongoing bacteremia
Fatigue and malaise from chronic infection and inflammation
New or worsening heart murmur indicating valvular involvement
Signs of embolic phenomena such as stroke, splenic infarcts, or limb ischemia
History of Present Illness
Fever and chills are the most common presenting symptoms reflecting systemic infection.
Fatigue, malaise, and weight loss develop gradually over weeks in subacute cases.
New or changing heart murmur indicates valvular involvement and damage.
Symptoms of embolic phenomena such as stroke or splenic infarcts may occur in advanced disease.
Night sweats and anorexia are common constitutional complaints.
Past Medical History
History of valvular heart disease including rheumatic fever or degenerative valve disease.
Previous endocarditis increases risk of recurrence with enterococci.
Recent genitourinary or gastrointestinal procedures that may have caused bacteremia.
Chronic indwelling catheters or prosthetic devices that predispose to bloodstream infection.
Immunosuppressive conditions or therapies that impair host defense.
Family History
[]
Physical Exam Findings
New or changing heart murmur, often a regurgitant murmur due to valvular damage
Petechiae on skin, conjunctiva, or mucous membranes from microemboli
Splinter hemorrhages under the fingernails indicating microvascular emboli
Janeway lesions, painless erythematous macules on palms and soles from septic emboli
Osler nodes, tender subcutaneous nodules on fingers or toes caused by immune complex deposition
Diagnostic Workup
Diagnostic Criteria
Diagnosis relies on the Duke criteria, which include major and minor clinical, microbiological, and echocardiographic findings. Key diagnostic features include positive blood cultures for Enterococcus faecium or faecalis from multiple samples and evidence of endocardial involvement on echocardiography, such as vegetations or abscesses. Additional minor criteria include fever, vascular phenomena, and immunologic signs. Confirmatory diagnosis requires integration of these findings to establish definite or possible infective endocarditis.
Pathophysiology
Key Mechanisms
Bacterial adherence to damaged endocardial surfaces via surface adhesins facilitates colonization by Enterococcus faecium/faecalis.
Vegetation formation composed of fibrin, platelets, and bacteria protects microbes from host immune clearance and antibiotics.
Biofilm production by enterococci enhances resistance to antimicrobial agents and host defenses.
Host immune response causes inflammation and tissue destruction leading to valvular damage and systemic emboli.
Bacteremia allows hematogenous seeding of cardiac valves, especially in the presence of pre-existing endothelial injury.
| Involvement | Details |
|---|---|
| Organs | Heart is the main organ affected, with infection leading to valvular destruction, regurgitation, and heart failure. |
Kidneys may be affected by immune complex deposition causing glomerulonephritis as a complication of endocarditis. | |
| Tissues | Cardiac valve tissue is the primary site of infection and vegetation formation in enterococcal endocarditis. |
Endocardium is the inner lining of the heart chambers and valves that becomes inflamed and damaged during infection. | |
| Cells | Neutrophils are the primary immune cells that infiltrate infected heart valves and mediate bacterial clearance. |
Macrophages contribute to phagocytosis of bacteria and release of inflammatory cytokines in infected tissues. | |
Endothelial cells lining the heart valves become damaged and serve as a nidus for bacterial adherence and vegetation formation. | |
| Chemical Mediators | Interleukin-1 (IL-1) promotes inflammation and fever during infective endocarditis. |
Tumor necrosis factor-alpha (TNF-α) mediates systemic inflammatory response and tissue damage. | |
C-reactive protein (CRP) is an acute phase reactant elevated in response to infection and inflammation. |
Treatments
Pharmacological Treatments
Ampicillin
- Mechanism:
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.
- Side effects:
Allergic reactions
Gastrointestinal upset
Rash
- Clinical role:
First-line
Gentamicin
- Mechanism:
Binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting protein synthesis.
- Side effects:
Nephrotoxicity
Ototoxicity
Neuromuscular blockade
- Clinical role:
Adjunctive
Vancomycin
- Mechanism:
Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors.
- Side effects:
Nephrotoxicity
Red man syndrome
Ototoxicity
- Clinical role:
First-line for resistant strains
Linezolid
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit and preventing formation of the initiation complex.
- Side effects:
Bone marrow suppression
Peripheral neuropathy
Serotonin syndrome
- Clinical role:
Second-line for resistant strains
Non-pharmacological Treatments
Surgical valve repair or replacement is indicated in cases of severe valvular dysfunction, persistent infection, or large vegetations.
Removal of infected intravascular devices or catheters to eliminate the source of bacteremia.
Supportive care including management of heart failure and embolic complications.
Prevention
Pharmacological Prevention
Antibiotic prophylaxis with amoxicillin or ampicillin prior to high-risk dental or genitourinary procedures in patients with high-risk cardiac conditions
Use of combination therapy (e.g., ampicillin plus gentamicin) for treatment to prevent relapse
Avoidance of unnecessary invasive procedures to reduce bacteremia risk
Prompt treatment of urinary tract infections to prevent bacteremia
Monitoring and adjusting antibiotics based on susceptibility testing to prevent resistance
Non-pharmacological Prevention
Good dental hygiene and regular dental care to reduce oral bacterial load
Careful aseptic technique during genitourinary and gastrointestinal procedures
Screening and management of valvular heart disease to reduce susceptibility
Avoidance of intravenous drug use to prevent bacteremia
Close follow-up and monitoring in patients with prosthetic valves or prior endocarditis
Outcome & Complications
Complications
Heart failure due to valvular destruction and regurgitation
Systemic embolization causing stroke, splenic infarcts, or peripheral ischemia
Perivalvular abscess formation leading to conduction abnormalities or fistulas
Septic shock from uncontrolled bacteremia
Glomerulonephritis from immune complex deposition
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Endocarditis (Enterococcus faecium/faecalis) versus Staphylococcus aureus Endocarditis
Endocarditis (Enterococcus faecium/faecalis) | Staphylococcus aureus Endocarditis |
|---|---|
Gram-positive cocci in pairs and chains, often resistant to vancomycin | Gram-positive cocci in clusters, often methicillin-resistant |
Commonly linked to genitourinary or gastrointestinal procedures | Often associated with intravenous drug use or healthcare exposure |
Subacute course with less aggressive tissue destruction | Rapidly progressive with high risk of metastatic abscesses |
Endocarditis (Enterococcus faecium/faecalis) versus Viridans Group Streptococci Endocarditis
Endocarditis (Enterococcus faecium/faecalis) | Viridans Group Streptococci Endocarditis |
|---|---|
Enterococci, gamma-hemolytic, bile esculin positive | Alpha-hemolytic streptococci, optochin resistant |
Frequently follows genitourinary or gastrointestinal manipulation | Often follows dental procedures or poor dental hygiene |
Often requires combination therapy with aminoglycosides due to resistance | Usually sensitive to penicillin alone |
Endocarditis (Enterococcus faecium/faecalis) versus Nonbacterial Thrombotic Endocarditis (NBTE)
Endocarditis (Enterococcus faecium/faecalis) | Nonbacterial Thrombotic Endocarditis (NBTE) |
|---|---|
Vegetations containing live bacteria, confirmed by culture | Sterile vegetations composed of fibrin and platelets without microorganisms |
Presents with systemic infection signs and positive blood cultures | Associated with hypercoagulable states and malignancy, often asymptomatic |
Positive blood cultures for enterococci species | Negative blood cultures despite vegetations on echocardiogram |
Endocarditis (Enterococcus faecium/faecalis) versus Prosthetic Valve Endocarditis
Endocarditis (Enterococcus faecium/faecalis) | Prosthetic Valve Endocarditis |
|---|---|
Native valve without prior prosthetic implantation | History of valve replacement surgery |
Enterococcus faecalis/faecium as causative agents | Often caused by coagulase-negative staphylococci or Staphylococcus aureus |
Vegetations localized to native valve leaflets without abscess | Perivalvular abscess and prosthetic dehiscence on echocardiogram |